Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-an updated analysis

被引：19
|
作者：
Younus, J. [1 ]
Vandenberg, T. [1 ]
Jawaid, M. [2 ]
Jawaid, M. A. [3 ]
机构：
[1] London Reg Canc Program, Dept Med Oncol, London, ON N6A 4L6, Canada
[2] Univ Western Ontario, Schulich Sch Med, London, ON, Canada
[3] Univ Western Ontario, Dept Social Sci, London, ON, Canada
来源：
CURRENT ONCOLOGY | 2012年 / 19卷 / 06期
关键词：
Febrile neutropenia; breast cancer; adjuvant chemotherapy; RANDOMIZED-TRIALS; METAANALYSIS; DOXORUBICIN; OUTCOMES; OLDER;
D O I：
10.3747/co.19.1174
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：332 / 334
页数：3
相关论文
共 50 条
  • [1] Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice-a retrospective analysis
    Vandenberg, T.
    Younus, J.
    Al-Khayyat, S.
    CURRENT ONCOLOGY, 2010, 17 (02) : 56 - 57
  • [2] Febrile neutropenia with adjuvant docetaxel and cyclophosphamide (TC) chemotherapy for breast cancer.
    Yu, Joanne Linda
    Kurin, Michael
    Pasetka, Mark
    Sridhar, Srikala S.
    Warner, Ellen
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Incidence of febrile neutropenia with adjuvant docetaxel and cyclophosphamide in patients with early breast cancer
    Marinho, F. D. S.
    Lopes, M. D. S. D. S.
    Monteiro, M. M. F.
    Gifoni, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] Febrile neutropenia rates during docetaxel and cyclophosphamide (TC) adjuvant therapy in early breast cancer (EBC)
    Kotasek, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] High incidence of febrile neutropenia seen following adjuvant chemotherapy with docetaxel plus cyclophosphamide for early breast cancer
    Gilbar, Peter
    McPherson, Ian
    Sorour, Natacha
    Sanmugarajah, Jasotha
    Francesconi, Alessandra
    McCaffrey, Elizabeth
    BREAST CANCER MANAGEMENT, 2014, 3 (01) : 9 - 11
  • [6] Primary prophylaxis of febrile neutropenia during adjuvant docetaxel and cyclophosphamide (TC) chemotherapy for breast cancer
    Yu, J. L.
    Kurin, M.
    Pasetka, M.
    Kiss, A.
    Chan, K.
    Sridhar, S. S.
    Warner, E.
    CANCER RESEARCH, 2013, 73
  • [7] Chemotherapy Induced Febrile Neutropenia of Docetaxel with Cyclophosphamide (TC) for Adjuvant Therapy of Breast Cancer in the Community-Reality Check
    Myers, R.
    Higgins, B.
    Jeffrey, M.
    Mova, L.
    Rajagopal, S.
    Jones, G.
    Stakiw, J.
    CANCER RESEARCH, 2009, 69 (24) : 623S - 623S
  • [8] Incidence of Febrile Neutropenia in Patients Treated with Docetaxel and Cyclophosphamide (TC) for Adjuvant Breast Cancer
    Yee, J.
    Chan, J.
    Fehrenbacher, L.
    Fredriks, D.
    Chen, D.
    Wong, W.
    Colley, D.
    CANCER RESEARCH, 2011, 71
  • [9] Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in patients with breast cancer: A retrospective analysis
    Ngamphaiboon, N.
    Advani, P. P.
    O'Connor, T. L.
    Ademuyiwa, F. O.
    Levine, E. G.
    Riebandt, G.
    Kossoff, E. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Febrile neutropenia in adjuvant docetaxel and cyclophosphamide (TC) with prophylactic pegfilgrastim in breast cancer patients: a retrospective analysis
    Nuttapong Ngamphaiboon
    Tracey L. O’Connor
    Pooja P. Advani
    Ellis G. Levine
    Ellen B. Kossoff
    Medical Oncology, 2012, 29 : 1495 - 1501
12345